Literature DB >> 9765483

Epstein-Barr virus small RNA (EBER) genes: differential regulation during lytic viral replication.

N Greifenegger1, M Jäger, L A Kunz-Schughart, H Wolf, F Schwarzmann.   

Abstract

In every latently Epstein-Barr virus-infected cell the viral genes EBER-1 and EBER-2 are transcribed by polymerase III. In lytically infected cells in vivo the EBER genes could not be detected. However, in cell culture downregulation could not be confirmed, and hence the relevance of this shutdown to the replication of the virus was not clear. We assayed the transcriptional activity of the EBER genes by nuclear run-on assays with enriched lytically infected cells and demonstrated that EBER-1 and EBER-2 are differentially downregulated on the transcriptional level during the switch to lytic viral replication. This downregulation was an early event during the lytic replication of the virus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765483      PMCID: PMC110355     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.

Authors:  S Swaminathan; B Tomkinson; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

2.  Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication.

Authors:  R Weigel; D K Fischer; L Heston; G Miller
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

3.  Transcriptional regulation of hemoglobin switching in chicken embryos.

Authors:  M Groudine; M Peretz; H Weintraub
Journal:  Mol Cell Biol       Date:  1981-03       Impact factor: 4.272

4.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.

Authors:  M E Greenberg; E B Ziff
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

Review 5.  Epstein-Barr virus (EBV), lymphocytes and transformation.

Authors:  J Zeuthen
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

6.  Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization.

Authors:  J G Howe; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia.

Authors:  K Gilligan; P Rajadurai; L Resnick; N Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements.

Authors:  J G Howe; M D Shu
Journal:  Cell       Date:  1989-06-02       Impact factor: 41.582

Review 9.  The control of lytic replication of Epstein-Barr virus in B lymphocytes (Review).

Authors:  F Schwarzmann; M Jäger; N Prang; H Wolf
Journal:  Int J Mol Med       Date:  1998-01       Impact factor: 4.101

10.  Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus.

Authors:  M R Lerner; N C Andrews; G Miller; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  18 in total

1.  Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP.

Authors:  B Wensing; A Stühler; P Jenkins; M Hollyoake; C E Karstegl; P J Farrell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Efficient transcription of the EBER2 gene depends on the structural integrity of the RNA.

Authors:  Edda Dümpelmann; Hendrik Mittendorf; Bernd-Joachim Benecke
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

3.  Viral response to chemotherapy in endemic burkitt lymphoma.

Authors:  Weihua Tang; Paula Harmon; Margaret L Gulley; Charles Mwansambo; Peter N Kazembe; Francis Martinson; Clifford Wokocha; Shannon C Kenney; Irving Hoffman; Carlie Sigel; Susan Maygarden; Mariah Hoffman; Carol Shores
Journal:  Clin Cancer Res       Date:  2010-03-16       Impact factor: 12.531

4.  EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA.

Authors:  Nara Lee; Walter N Moss; Therese A Yario; Joan A Steitz
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

5.  Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation.

Authors:  Jeremy Poppers; Matthew Mulvey; Cesar Perez; David Khoo; Ian Mohr
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR.

Authors:  Ingrid K Ruf; Kristen A Lackey; Swati Warudkar; Jeffery T Sample
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.

Authors:  S A Sargsyan; A J Shearer; A M Ritchie; M P Burgoon; S Anderson; B Hemmer; C Stadelmann; S Gattenlöhner; G P Owens; D Gilden; J L Bennett
Journal:  Neurology       Date:  2010-03-10       Impact factor: 9.910

8.  A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease.

Authors:  Yan-Jun Gan; Bassem I Razzouk; Tao Su; John W Sixbey
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

9.  Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Authors:  Thomas J Owen; John D O'Neil; Christopher W Dawson; Chunfang Hu; Xiaoyi Chen; Yunhong Yao; Victoria H J Wood; Louise E Mitchell; Robert J White; Lawrence S Young; John R Arrand
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

10.  Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer.

Authors:  J Huang; H Chen; L Hutt-Fletcher; R F Ambinder; S D Hayward
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.